Zobrazeno 1 - 10
of 82
pro vyhledávání: '"G D Efremov"'
Publikováno v:
Сибирский онкологический журнал, Vol 22, Iss 4, Pp 142-148 (2023)
Background. According to literature data, errors in the diagnosis of gastrointestinal tumors (GIST) are uncommon, accounting for approximately 6% of cases that results in treatment failure. Case report. Here, we describe a rare case of a 58-year-old
Externí odkaz:
https://doaj.org/article/a3c380b4e9ef45fc862f60aefcbc0d71
Publikováno v:
Alʹmanah Kliničeskoj Mediciny, Vol 44, Iss 5, Pp 558-567 (2017)
In the recent years, the full exome sequencing helped to reveal a set of mutations in the genes that are not oncogenes or tumor suppressor genes by definition, but play an important role in carcinogenesis and encode proteins involved in chromatin rem
Externí odkaz:
https://doaj.org/article/f3da2f36484e4ae3a57e610fca5df1b1
Autor:
A. V. Sivkov, N. G. Keshishev, G. D. Efremov, G. A. Kovchenko, A. A. Trudov, L. M. Nikonova, F. D. Romikh
Publikováno v:
Issledovaniâ i Praktika v Medicine, Vol 2, Iss 1, Pp 55-60 (2015)
The principal marker of neuroendocrine differentiation (NED) is chromogranin A (HGA). The purpose of this work is to determine the role of NED in diseases of the prostate gland by the level of HGA.Materials and methods. The study included 304 men wit
Externí odkaz:
https://doaj.org/article/b2fbc8dae9a84ee4b4bb9c1034b48947
Autor:
D. S. Mikhaylenko, S. A. Sergienko, E. B. Kuznetsova, I. N. Zaborsky, M. I. Martynov, O. B. Loran, G. D. Efremov, S. A. Samoylova, B. Ya. Alekseev, V. V. Musatova, I. V. Bure, M. V. Nemtsova
Publikováno v:
Onkourologiâ, Vol 17, Iss 1, Pp 89-100 (2021)
Background. Bladder cancer (BC) is a common urological cancer, 75 % of which are non-muscle invasive BC. After removal of the primary tumor, the adequate classification of malignancy and the defining of tumor progression risk remains an important iss
Autor:
O. V. Kovaleva, M. A. Rashidova, D. V. Samoilova, P. A. Podlesnaya, R. M. Tabiev, N. V. Kuntsevich, G. D. Efremov, B. Ya. Alekseev, A. N. Gratchev
Publikováno v:
Onkourologiâ, Vol 16, Iss 2, Pp 29-35 (2020)
Background. Renal cell carcinoma is a heterogeneous group of tumors characterized by high vascularization and immunogenicity. Immunotherapy has made a breakthrough in the treatment of this pathology, however, the lack of development of criteria for i
Autor:
N. Yu. Safronova, G. D. Efremov, Andrey Kaprin, Dmitry S. Mikhaylenko, B. Ya. Alekseev, S. A. Sergienko
Publikováno v:
Experimental and Сlinical Urology. 12:42-51
Autor:
Dmitry S. Mikhaylenko, G. D. Efremov, I Y Sobol, O A Simonova, Marina V. Nemtsova, E.A. Efremov, B Y Alekseev, A D Kaprin, N Y Safronova
Publikováno v:
Urologiia. :101-107
AIM microdeletions in the AZF region of Y-chromosome, compound heterozygotes of severe and mild CFTR mutations, and long CAG-repeats in the androgen receptor gene (AR) as marker of predisposition are frequently studied as genetic causes of male infer
Publikováno v:
Bulletin of Experimental Biology and Medicine. 166:497-502
The abdominal type of cryptorchism was modeled on random-bred albino rats by replacing both testes from the scrotum into the abdominal cavity for 3 weeks; thereupon they were manipulated into the scrotum. In control rats, no additional surgery was pe
Autor:
D. S. Mikhaylenko, A. A. Novikov, M. V. Grigor’eva, G. D. Efremov, A. V. Sivkov, N. Yu. Safronova, K. S. Sorokin, M. Yu. Zemskova, M. V. Nemtsova, B. Ya. Alekseev, A. D. Kaprin
Publikováno v:
Onkourologiâ, Vol 13, Iss 3, Pp 54-60 (2017)
Introduction . Prostate cancer (PCa) is one of the common oncological diseases in men. Expression of the PCA3 gene in urine is currently used as a molecular genetic marker of PCa. Objective: to comparative analysis of the PCA3 expression in urine sed
Autor:
D. S. Mikhaylenko, M. V. Teleshova, D. V. Perepechin, G D. Efremov, D. Yu. Kachanov, E. V. Raykina, V. O. Bobrynina, S. G. Lavrina, A. M. Mitrofanova, D. M. Konovalov, S. R. Varfolomeeva, B. Ya. Alekseev
Publikováno v:
Onkourologiâ, Vol 13, Iss 2, Pp 14-19 (2017)
The malignant rhabdoid tumor (RT) is one of the most aggressive childhood neoplasm. RTs are characterized by the presence of inactivating mutations in the SMARCB1 (hSNF5/INI1/BAF47) gene – a tumor suppressor localized in 22q11.2. Up to 30 % of RTs